
EurekaBio
EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
$40M Series B+ ·
Source: startupintros.com
Funding history ↓Signals
Website registeredNov 12, 2013 (13 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $40M | — | startupintros.com |
Timeline
- Website created
Companies like EurekaBio
TTensiveSeries A · Jan 2025MMyeloid TherapeuticsSeries B+ · May 2026
SSparrow Quantum$32M Series A · Dec 2025
EEpilepsy GTx$33M Series A · Dec 2025
PPCVPre Seed
GGigaton$26M · Jun 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/eurekabio (get a free API key).